Accuray (ARAY) Interest & Investment Income (2013 - 2025)
Accuray's (ARAY) quarterly Interest & Investment Income came in at $272000.0 in Q3 2025, down 10.23% year-on-year from $303000.0 in Q3 2024, and up 119.67% quarter-over-quarter from -$1.4 million in Q2 2025.
Accuray (ARAY) Interest & Investment Income (2013 - 2025) Analysis & Trends
Accuray's Interest & Investment Income history runs 11 years deep, the most recent figure standing at $272000.0 for Q3 2025.
- On a quarterly basis, Interest & Investment Income fell 10.23% year-over-year to $272000.0 in Q3 2025; TTM through Sep 2025 was $1.8 million, a 14.77% increase from a year earlier, with the FY2025 full-year figure at -$1.4 million, down 212.35% from the prior year.
- Interest & Investment Income rose to $272000.0 in Q3 2025 per ARAY's latest filing, from -$1.4 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $956000.0 in Q1 2024 and bottomed at -$3.9 million in Q2 2022.
- The 4-year median for Interest & Investment Income is $269500.0 (2023), against an average of -$566000.0.
- Across the five-year window, Interest & Investment Income jumped 79.85% in 2024 and slumped 149.19% in 2025, its largest moves.
- Year by year, Interest & Investment Income stood at -$3.9 million in 2022, then jumped by 106.76% to $267000.0 in 2023, then advanced by 4.12% to $278000.0 in 2024, then slipped by 2.16% to $272000.0 in 2025.
- Per Business Quant, the three latest ARAY Interest & Investment Income figures stand at $272000.0 (Q3 2025), -$1.4 million (Q2 2025), and $903000.0 (Q1 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 106.00 Mn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 33.50 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 40.98 Mn |
| 10 | Accuray | 27,968.40 | -38.51 Mn | 25.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 272,000.00 |
| Jun 30, 2025 | -1.38 Mn |
| Mar 31, 2025 | 903,000.00 |
| Dec 31, 2024 | 278,000.00 |
| Sep 30, 2024 | 303,000.00 |
| Jun 30, 2024 | -555,000.00 |
| Mar 31, 2024 | 956,000.00 |
| Dec 31, 2023 | 267,000.00 |
| Jun 30, 2023 | -2.75 Mn |
| Jun 30, 2022 | -3.95 Mn |
| Jun 30, 2020 | 1.24 Mn |
| Jun 30, 2018 | 144,000.00 |
| Jun 30, 2017 | 1.12 Mn |
| Jun 30, 2016 | 4,000.00 |
| Mar 31, 2016 | 149,000.00 |
| Dec 31, 2015 | -128,000.00 |
| Sep 30, 2015 | 38,000.00 |
| Jun 30, 2015 | -10,000.00 |
| Mar 31, 2015 | 54,000.00 |
| Dec 31, 2014 | 2,000.00 |